African americans may differ in their reasons for declining hepatitis c therapy compared to non-african americans

Digestive Diseases and Sciences

Volumn 54, Issue 7, 2009, Pages 1604-1605

  Borum, Marie L ^a   Igiehon, Enaruna ^a   Shafa, Shervin ^a   Khokhar, Omar S ^b   Lewis, James H ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

AFRICAN AMERICAN; CAUCASIAN; HEPATITIS C; HUMAN; LETTER; MEDICAL RECORD; PATIENT DECISION MAKING; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT REFUSAL;

AFRICAN AMERICANS; ANTIVIRAL AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; PATIENT SATISFACTION; TREATMENT REFUSAL;

EID: 67349188218     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0806-4     Document Type: Letter

References (4)

1. OS Khokhar JH Lewis 2007 Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? Dig Dis Sci 52 5 1168 1176 10.1007/s10620-006-9579-1
2. AJ Muir JD Bornstein PG Killenberg 2004 Peginterferon alfa-2b and ribavarin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Engl J Med 350 226 2271 10.1056/NEJMoa032502
3. S Srivastava M Bertagnoli JH Lewis 2005 Sustained virological response rate to pegylated interferone plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a University Liver Clinic JAMA 97 1703 1707 (Pubitemid 41753117)
4. S Elgawly OS Khokhar JH Lewis 2007 Satisfaction with the decision to defer treatment for chronic hepatitis C declines over time: results of a 2-year follow-up questionnaire survey Gastroenterology 132 4 suppl 2 abstract M1870 A-793 A-794